Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dela Peña, Ike | - |
dc.contributor.author | Kim, Bung-Nyun | - |
dc.contributor.author | Han, Doug Hyun | - |
dc.contributor.author | Kim, Yeni | - |
dc.contributor.author | Cheong, Jae Hoon | - |
dc.date.accessioned | 2024-01-26T04:30:57Z | - |
dc.date.available | 2024-01-26T04:30:57Z | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71562 | - |
dc.description.abstract | Methylphenidate is the most prescribed stimulant medication for attention-deficit/hyperactivity disorder (ADHD). Despite the well documented clinical benefits of the drug, several questions remain unanswered concerning the effects of extended methylphenidate use (e.g. can methylphenidate be abused by ADHD patients? does repeated methylphenidate treatment produce addiction?). Preclinical studies can help address the long-term safety of clinical treatments, moreover animal studies provide valuable information on the details of drug actions. The spontaneously hypertensive rat (SHR), bred from normotensive Wistar Kyoto rat strain, is considered as the best validated and the most widely used animal model of ADHD. We reviewed the findings of research reports that investigated the abuse and dependence liability of methylphenidate in SHR. In particular, we surveyed the studies which investigated the effects of methylphenidate pretreatment on subsequent methylphenidate-induced conditioned place preference or self-administration for they may give insights into the abuse or dependence liability of long-term methylphenidate treatment in ADHD. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned? | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12272-013-0037-2 | - |
dc.identifier.bibliographicCitation | Archives of pharmacal research, v.36, no.4, pp 400 - 410 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 410 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 400 | - |
dc.citation.title | Archives of pharmacal research | - |
dc.citation.volume | 36 | - |
dc.type.docType | Journal Article;Research Support, Non-U.S. Gov't;Review | - |
dc.publisher.location | 대한민국 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.